Artwork
iconShare
 
Manage episode 518107764 series 3361449
Content provided by Labiotech. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Labiotech or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Urinary Tract infections, or UTIs, affect millions worldwide, driving sepsis, antibiotic overuse, and microbial resistance. Current diagnostics rely on either slow lab cultures or unreliable dipsticks, and often lead to delayed or unnecessary treatment. Llusern’s Lodestar DX changes that: a point-of-care test that detects 96% of key UTI pathogens in just 35 minutes, no lab required.

In this episode I’m joined by Emma Hayhurst who shares her journey into diagnostics, Llusern’s mission, and the emergence of Wales as a biotech hub with a growing life sciences sector fueling local innovation. We discuss UTI prevalence, diagnostic gaps, and how rapid, accurate testing can transform patient care and antimicrobial stewardship.

02:14 Meet Emma Hayhurst

04:37 Introducing Llusern Scientific

07:21 Collaboration between Llusern and the academy

08:50 The life science ecosystem in Wales

12:10 Urinary tract infections (UTIs)

15:45 UTI patient demographics

16:54 Health impacts of UTIs: sepsis, antibiotic resistance, and more

19:01 Existing UTI diagnostic options and their shortcomings

24:41 Llusern’s Lodestar DX

29:03 A point-of-care test, not a lab test

31:44 Applications beyond UTIs

36:03 Looking forward at Llusern

Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

To dive deeper into the topic:

  continue reading

Chapters

1. Next‑generation UTI diagnostics: delivering results in just 35 minutes (00:00:00)

2. Meet Emma Hayhurst (00:02:14)

3. Introducing Llusern Scientific (00:04:37)

4. Collaboration between Llusern and the academy (00:07:21)

5. The life science ecosystem in Wales (00:08:50)

6. Urinary tract infections (UTIs) (00:12:10)

7. UTI patient demographics (00:15:45)

8. Health impacts of UTIs: sepsis, antibiotic resistance, and more (00:16:54)

9. Existing UTI diagnostic options and their shortcomings (00:19:01)

10. Llusern’s Lodestar DX (00:24:41)

11. A point-of-care test, not a lab test (00:29:03)

12. Applications beyond UTIs (00:31:44)

13. Looking forward at Llusern (00:36:03)

172 episodes